Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade

T Epistent Investigators · The Lancet · 1998 · 1.4K citations

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +9

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade

Eric J. Topol · The Lancet · 1998 · 1.1K citations

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +9

In-Stent Restenosis: Contributions of Inflammatory Responses and Arterial Injury to Neointimal Hyperplasia

Ran Kornowski, Mun K. Hong, Fermin O. Tio et al. · Journal of the American College of Cardiology · 1998 · 842 citations

Inflammation, Inflammatory Responses, Vascular Disease +11

Predictive Factors of Restenosis After Coronary Stent Placement

Adnan Kastrati, Albert Schömig, Shpend Elezi et al. · Journal of the American College of Cardiology · 1997 · 680 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Predictive Factors +6

Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism

V A Danis, Michelle Millington, V.J. Hyland et al. · Clinical & Experimental Immunology · 1995 · 530 citations · Full text